Kira Biotech is a biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and type 1 diabetes. Its lead candidate, KB312, is a selective, immune-cell depleting monoclonal antibody that targets activated immune cells and aims to restore homeostasis through induction of immune tolerance.
|HQ||Fortitude Valley, AU||Map|
|Employees (est.) (Jan 2020)||4|
Kira Biotech total Funding
Kira Biotech latest funding size
Time since last funding
|3 months ago|
Kira Biotech investors
|IP Group Plc, Queensland Business Development Fund, OneVentures|
When was Kira Biotech founded?
Kira Biotech was founded in 2019.
Who are Kira Biotech key executives?
Kira Biotech's key executives are Siro Perez, Dan Baker and Helen Roberts.
How many employees does Kira Biotech have?
Kira Biotech has 4 employees.
Who are Kira Biotech competitors?
Competitors of Kira Biotech include Dermala, Syntimmune and Lodo Therapeutics.
Where is Kira Biotech headquarters?
Kira Biotech headquarters is located at Level 2/315 Brunswick St, Fortitude Valley.
Where are Kira Biotech offices?
Kira Biotech has an office in Fortitude Valley.
How many offices does Kira Biotech have?
Kira Biotech has 1 office.
Receive alerts for 300+ data fields across thousands of companies